Pharmacological evaluation and chemical stability of 2‐benzylthioether‐5′‐O‐(1‐thiotriphosphate)‐adenosine, a new insulin secretagogue acting through P2Y receptors

Activation of P2Y receptors on pancreatic β‐cells by extracellular ATP bring about amplification of glucose‐induced insulin secretion, which has been shown to reduce hyperglycemia in vivo. A new P2 receptor ligand, 2‐benzylthio‐ATP‐α‐S, was synthesized based on a combination of modifications of the ATP skeleton, as a potential insulin secretagogue. The two diastereoisomers of this ligand were separated and are designated A and B. The effects of these compounds on insulin secretion and vascular resistance in the rat isolated and perfused pancreas were evaluated in the presence of a slightly stimulating glucose concentration (8.3 mM) and were compared with ATP‐α‐S and ATP. Both isomers of 2‐benzylthio‐ATP‐α‐S (0.015–1.5 μM) induced a concentration‐dependent increase in glucose‐induced insulin release. The potency of isomer A was not significantly different from that of isomer B, and both were approximately 100‐fold more potent than ATP. ATP‐α‐S induced a similar pattern of insulin response; however, it was only approximately 10‐fold more potent than ATP. These compounds also induced vascular effects: ATP‐α‐S induced a vasodilatation and was transiently vasoconstrictor only at a high concentration, whereas the C2‐substituted derivative constantly induced a vasoconstriction. The chemical stability of these ligands was evaluated under physiological conditions and gastric juice pH. Hydrolysis of 2‐benzylthio‐ATP‐α‐S has been studied both in pH 7.4 and pH 1.4 at 37°C using 31P nuclear magnetic resonance (NMR) spectroscopy and high‐performance liquid chromatography. This compound exhibited high chemical stability with respect to hydrolysis of the glycosidic bond and desulfurization of the phosphorothioate moiety. Hydrolysis of the phospho ester bond, which was the only detectable degrading reaction under the investigation conditions (pH 7.4, 37°C), was slow, with a half‐life of 264 h. Moreover, even at gastric juice conditions (pH 1.4, 37°C), hydrolysis of the terminal phosphate was the only detectable reaction, with half‐life of 17.5 h. In conclusion, both isomers of 2‐benzylthio‐ATP‐α‐S are soluble in water and highly chemically stable. These compounds are highly potent and effective insulin secretagogues; however, they increase pancreatic vascular resistance. Drug Dev. Res. 53:33–43, 2001. © 2001 Wiley‐Liss, Inc.

[1]  A. Chulkin,et al.  2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors. , 1999, The Israel Medical Association journal : IMAJ.

[2]  P. Petit,et al.  Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell , 1998, British journal of pharmacology.

[3]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[4]  G. Bertrand,et al.  Comparative effects of adenosine‐5′‐triphosphate and related analogues on insulin secretion from the rat pancreas , 1997, Fundamental & clinical pharmacology.

[5]  K. Jacobson,et al.  A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. , 1997, Molecular pharmacology.

[6]  H. Lönnberg,et al.  Hydrolysis and Desulfurization of the Diastereomeric Phosphoromonothioate Analogs of Uridine 2',3'-Cyclic Monophosphate. , 1996, The Journal of organic chemistry.

[7]  H. Lönnberg,et al.  Hydrolytic dethiophosphorylation and desulfurization of the monothioate analogues of uridine monophosphates under acidic conditions , 1996 .

[8]  K. Jacobson,et al.  Modelling the P2Y purinoceptor using rhodopsin as template. , 1995, Drug design and discovery.

[9]  R. Strömberg,et al.  Hydrolytic Reactions of the Diastereomeric Phosphoromonothioate Analogs of Uridylyl(3',5')uridine: Kinetics and Mechanisms for Desulfurization, Phosphoester Hydrolysis, and Transesterification to the 2',5'-Isomers , 1995 .

[10]  G. Bertrand,et al.  Effects of Purinoceptor Agonists on Insulin Secretion , 1995 .

[11]  R. North,et al.  A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP , 1994, Nature.

[12]  J. Décout,et al.  Hydrolysis of 2′-deoxypurine nucleosides. The effect of substitution at the C-8 position , 1994 .

[13]  G. Burnstock,et al.  Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypes , 1994 .

[14]  G. Burnstock,et al.  Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate. , 1993, Journal of medicinal chemistry.

[15]  D. Julius,et al.  Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Bertrand,et al.  Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y‐purinoceptor agonist, adenosine‐5′‐O‐(2‐thiodiphosphate) , 1993, British journal of pharmacology.

[17]  S. Hourani,et al.  Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T‐purinoceptors on human blood platelets , 1993, British journal of pharmacology.

[18]  D. Hillaire‐buys,et al.  P2y purinoceptor responses of β cells and vascular bed are preserved in diabetic rat pancreas , 1992, British journal of pharmacology.

[19]  P. Petit,et al.  Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes. , 1991, European journal of pharmacology.

[20]  G. Bertrand,et al.  Adenosine‐5′‐O‐(2‐thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas , 1991, British journal of pharmacology.

[21]  J. Chattopadhyaya,et al.  Spectroscopic, kinetic and semiempirical molecular orbital studies on 8-amino-, 8-methylamino- & 8-dimethylamino-adenosines , 1991 .

[22]  G. Bertrand,et al.  P2 purinoceptor agonists stimulate somatostatin secretion from dog pancreas. , 1990, European journal of pharmacology.

[23]  D. S. Cowen,et al.  Activation of inositol phospholipid breakdown in HL60 cells by P2-purinergic receptors for extracellular ATP. Evidence for mediation by both pertussis toxin-sensitive and pertussis toxin-insensitive mechanisms. , 1988, The Journal of biological chemistry.

[24]  P. Petit,et al.  Differential effects of purinergic and cholinergic activation on the hydrolysis of membrane polyphosphoinositides in rat pancreatic islets. , 1988, Biochemical pharmacology.

[25]  G. Bertrand,et al.  Evidence for two different P2‐purinoceptors on β cell and pancreatic vascular bed , 1987, British journal of pharmacology.

[26]  M. Loubatières-Mariani,et al.  Evidence for purinergic receptors on vascular smooth muscle in rat pancreas. , 1983, European journal of pharmacology.

[27]  P. Lehikoinen,et al.  Mechanisms for solvolytic decompositions of nucleoside analogues. X. Acicic hydrolysis of 6-substituted 9-(β-D-ribofuranosyl)purines , 1982 .

[28]  S. Hourani,et al.  PARTIAL AGONIST BEHAVIOUR OF ADENOSINE 5′O‐(2‐THIODIPHOSPHATE) ON HUMAN PLATELETS , 1981, British journal of pharmacology.

[29]  M. Loubatières-Mariani,et al.  EFFECTS OF PHOSPHATE‐MODIFIED ADENINE NUCLEOTIDE ANALOGUES ON INSULIN SECRETION FROM PERFUSED RAT PANCREAS , 1981, British journal of pharmacology.

[30]  M. Loubatières-Mariani,et al.  Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. , 1979, European journal of pharmacology.

[31]  E. R. Garrett,et al.  Solvolysis of adenine nucleosides. I. Effects of sugars and adenine substituents on acid solvolyses. , 1972, Journal of the American Chemical Society.

[32]  R. K. Robins,et al.  A study on the relative stability and a quantitative appraoch to the reaction mechanism of the acid-catalyzed hydrolysis of certain7-and9- -D-ribofuranosylpurines. , 1972, Journal of the American Chemical Society.

[33]  J. Zoltewicz,et al.  Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides. , 1970, Journal of the American Chemical Society.

[34]  A. W. Murray,et al.  Adenosine 5'-phosphorothioate. A nucleotide analog that is a substrate, competitive inhibitor, or regulator of some enzymes that interact with adenosine 5'-phosphate. , 1968, Biochemistry.

[35]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.